Patent · US Expired

Pyrimidinone fused bicyclic metalloproteinase inhibitors

US6828326B2 · kind B2 · utility

3Cited by
17References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2003
Grant dateDec 7, 2004
Priority date
Expiry dateAug 5, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to fused bicyclic metalloproteinase inhibitors of the formula wherein A, B, X, Y, and R1 are as defined in the specification, and to pharmaceutical compositions and methods of treating arthritis, inflammation, cancer and other disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.